David P. Hochman - Sep 24, 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Signature
/s/ Andrew Taylor, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
Sep 24, 2024
Transactions value $
$47,905
Form type
4
Date filed
9/26/2024, 08:15 AM
Previous filing
Aug 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Purchase $12.3K +2.5K +0.44% $4.91 570K Sep 24, 2024 Direct F1
transaction OBIO Common Stock Purchase $7.29K +1.5K +0.45% $4.86 335K Sep 25, 2024 By the DPH 2008 Trust F2
transaction OBIO Common Stock Purchase $9.48K +2K $4.74 2K Sep 25, 2024 By the Solomon Ascher Hochman 2019 Trust F3
transaction OBIO Common Stock Purchase $9.4K +2K $4.70 2K Sep 25, 2024 By the Hannah Hochman 2019 Trust F4
transaction OBIO Common Stock Purchase $9.46K +2K $4.73 2K Sep 25, 2024 By the Judah Herman Hochman 2019 Trust F5
holding OBIO Common Stock 3.14K Sep 24, 2024 By the NSH 2008 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $4.95. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.83 to $4.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Chief Executive Officer and Chairperson